SIGA Tech Stock
StockStockPrice
Historical dividends and forecast
SIGA Tech has so far distributed $0.60 in 2024. The next dividend will be paid on 11.04.2025
CHART BY
Frequently asked questions
What is SIGA Tech's market capitalization?
What is SIGA Tech's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for SIGA Tech?
What is SIGA Tech's revenue over the trailing twelve months?
What is the EBITDA for SIGA Tech?
What is the free cash flow of SIGA Tech?
What is the 5-year beta of SIGA Tech's stock?
How many employees does SIGA Tech have, and what sector and industry does it belong to?
What is the free float of SIGA Tech's shares?
Financials
Market Cap
$538.12M5Y beta
0.91EPS (TTM)
$1.162Free Float
40.51MP/E ratio (TTM)
6.49Revenue (TTM)
$172.96MEBITDA (TTM)
$103.38MFree Cashflow (TTM)
$73.77MPricing
Information
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the United States maintains a supply of TPOXX under Project BioShield. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. It uses third parties known as contract manufacturing organizations to procure commercial raw materials and supplies, and to manufacture TPOXX.
45
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker